TLRY

Tilray Brands, Inc. Common Stock

2.85

USD

-0.06

-2.23%

Nov 09, 13:05 UTC -5

Open

Tilray Brands, Inc. Common Stock (TLRY) Earnings

TLRY Earnings Reports

Positive Surprise Ratio

TLRY beat 5 of 22 last estimates.

23%

Next Report

Date of Next Report

Jan 06, 2027

Estimate for Q2 27 (Revenue/ EPS)

$270.00M

-$0.18

Implied change from Q1 27 (Revenue/ EPS)

+5.00%

-43.75%

Implied change from Q2 26 (Revenue/ EPS)

-4.16%

-56.10%

Tilray Brands, Inc. Common Stock earnings per share and revenue

On Oct 08, 2026, TLRY reported earnings of -0.32 USD per share (EPS) for Q1 27, missing the estimate of -0.20 USD, resulting in a -55.79% surprise. Revenue reached 257.15 million, compared to an expected 272.81 million, with a -5.74% difference. The market reacted with a -3.36% price change (close before vs. close after earnings).

Looking ahead to Q2 27, -- analysts forecast an EPS of -0.18 USD, with revenue projected to reach 270.00 million USD, implying an decrease of -43.75% EPS, and increase of 5.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Village Farms International, Inc. Common Shares

Report Date

Nov 09, 2026 For Q3 26

Estimate

$0.05

Actual

$0.08

Surprise

+48.42%

Aurora Cannabis Inc. Common Shares

Report Date

Nov 05, 2026 For Q2 27

Estimate

-$0.08

Actual

-$0.32

Surprise

-261.99%

Canopy Growth Corporation Common Shares

Report Date

Nov 06, 2026 For Q2 27

Estimate

-$0.03

Actual

-$0.01

Surprise

+71.75%

InfuSystem Holdings, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.13

Actual

$0.15

Surprise

+13.12%

Quanterix Corporation Common Stock

Report Date

Nov 09, 2026 For Q3 26

Estimate

-$0.44

Actual

-$0.46

Surprise

-3.67%

Apyx Medical Corporation Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.09

Actual

-$0.04

Surprise

+57.98%

Lantheus Holdings, Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.26

Actual

$1.68

Surprise

+32.47%

Haemonetics Corporation

Report Date

Nov 05, 2026 For Q2 27

Estimate

$1.30

Actual

$1.35

Surprise

+3.53%

Trulieve Cannabis Corp.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.07

Actual

$0.00

Surprise

-100.00%

Prestige Consumer Healthcare Inc.

Report Date

Nov 05, 2026 For Q2 27

Estimate

$1.08

Actual

$1.12

Surprise

+4.28%

FAQ

What were Tilray Brands, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2027?

For Q1 2027, Tilray Brands, Inc. Common Stock reported EPS of -$0.32, missing estimates by -55.79%, and revenue of $257.15M, -5.74% below expectations.

How did the market react to Tilray Brands, Inc. Common Stock's Q1 2027 earnings?

The stock price moved down -3.36%, changed from $3.71 before the earnings release to $3.59 the day after.

When is Tilray Brands, Inc. Common Stock expected to report next?

The next earning report is scheduled for Jan 06, 2027.

What are the forecasts for Tilray Brands, Inc. Common Stock's next earnings report?

Based on -- analysts, Tilray Brands, Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $270.00M for Q2 2027.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.